Page 17 - Mark Corrigan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3t Energy Group has announced that it has exchanged contracts with Petrofac on a major transformational acquisition for the purchase of its UK training centres.

Packed.House Seals New Deals with M&Ms and Grant Thornton January 29, 2021 The media and production company, Packed.House has secured the Mars-owned M&Ms brand as the sponsor of its on-demand and streaming section on entertainment.ie for a second year the second year in a row. The partnership was brokered by Medicom. M&Ms will take full ownership of the on-demand and streaming section on entertainment.ie for the year bringing readers recommendations of movies and shows to watch arranged by genre. The Packed.House development team has also built a real time M&M’s On Demand Recommender widget...

Bitter feuds, death hoaxes and stage collapse - what Phoenix Nights cast did next Phoenix Nights won five awards across its two-year run, but as the show marks its 20th anniversary we take a look at what happened next for the Bolton Working Men’s Club regulars It's been 20 years since the much-loved show burst onto our screens (Image: Channel 4) Daily Star's Inside Hot TV newsletter sees Ed Gleave send you telly's hot takes straight to your inbox every SundayInvalid EmailSomething went wrong, please try again later. Yes, keep me in the know! When you subscribe we will use the information yo...

| UPDATED: 16:53, Fri, Jan 8, 2021 Link copied Sign up for FREE now for the biggest moments from morning TV SUBSCRIBE Invalid email When you subscribe we will use the information you provide to send you these newsletters. Sometimes they'll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time. Peep Show ran for 12 years and, since coming to an end in 2015, has remained a focal point of popular culture. An often uncomfortable insight into the lives of two male...

Share this article Share this article CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ -- Exacis Biotherapeutics, Inc., a development-stage immuno-oncology company working to harness the immune system to cure cancer, today announced its formation along with completion of in-licensing of certain technologies from Factor Bioscience, a leading cell sciences company. The exclusive license allows Exacis to create allogeneic engineered T and NK cells from induced pluripotent stem cells (iPSC). Exacis' next generation approach avoids use of DNA and viruses by using mRNA. The technologies will be...